参考文献/References:
[1] Casanova F,Gooding KM,Shore AC,et al.Weight change and sulfonylurea therapy are related to 3 year change in microvascular function in people with type 2 diabetes[J].Diabetologia,2020,63(6):1268-1278.
[2] Livingstone KM,Milte CM,Torres SJ,et al.Nineteen-year associations between three diet quality indices and all-cause and cardiovascular disease mortality:The australian diabetes,obesity and lifestyle study[J].J Nutr,2021,152(3):805-815.
[3] 李超杰,陈慧敏,濮先明.利拉鲁肽、格列美脲分别联用二甲双胍治疗肥胖型2型糖尿病疗效观察[J].陕西医学杂志,2021,50(3):356-358,373.
[4] 徐瑞颜,成金燕,李乐愚.复方番石榴合剂治疗超重肥胖型2型糖尿病疗效及对患者肠黏膜屏障功能的影响[J].陕西中医,2022,43(8):1045-1048.
[5] 秦高凤,王蓬文.黄连解毒汤对糖尿病脑病和阿尔茨海默病的作用[J].中华中医药学刊,2020,38(7):84-88.
[6] 迟家敏.实用糖尿病学[M].4版.北京:人民卫生出版社,2015:258-259.
[7] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:233-237.
[8] Heerspink HJL,Jongs N,Chertow GM,et al.Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes:A prespecified analysis from the dapa-ckd trial[J].Lancet Diabetes Endocrinol,2021,9(11):743-754.
[9] Carretero GJ,Ena J,Arevalo LJC,et al.Obesity is a chronic disease.positioning statement of the diabetes,obesity and nutrition workgroup of the Spanish Society of Internal Medicine(SEMI)for an approach centred on individuals with obesity[J].Rev Clin Esp(Barc),2021,221(9):509-516.
[10] 单 鸿,吴雁翔.肾衰宁胶囊联合替米沙坦对糖尿病肾病患者血管内皮功能及炎症因子水平的影响[J].成都医学院学报,2022,17(1):67-70.
[11] 李 翔,朱世滨,任 玲.健脾祛湿汤加二甲双胍治疗糖尿病的效果评估分析[J].辽宁中医杂志,2021,48(3):111-114.
[12] 韩 笑.从“脾壅络滞”探讨肥胖2型糖尿病胰岛素抵抗的中医病机及治疗[J].环球中医药,2019,12(4):535-536.
[13] 唐咸玉,曾慧妍,何 柳,等.近20年中医药防治肥胖2型糖尿病研究趋势可视化分析[J].中国中医药信息杂志,2018,25(4):96-101.
[14] 魏军平,晏蔚田.2型糖尿病合并肥胖的中西医防治策略述评[J].医学研究杂志,2022,51(1):1-5.
[15] 符绩军,刘志勇,胡 敏,等.黄连解毒汤联合低热量饮食对新诊断肥胖2型糖尿病血糖及胰岛素分泌影响的研究[J].中华中医药学刊,2022,40(12):143-145.
[16] 宋聪琳,张威娜.黄连解毒汤加减治疗2型糖尿病的临床疗效[J].辽宁中医杂志,2022,49(4):110-113.
[17] 巫海龙,谢嘉文,李向宇,等.加味黄连解毒汤联合利拉鲁肽对初发2型糖尿病肥胖患者糖脂代谢、炎症反应及胰岛功能的影响[J].现代生物医学进展,2020,20(19):3663-3667.
[18] 王晶璞,卢 燕,王 会,等.利拉鲁肽对肥胖型糖尿病患者空腹血糖、餐后2 h血糖、糖化血红蛋白水平产生的影响[J].河北医药,2021,43(6):897-900.
[19] 姚 兰,蒋成霞,郭艳艳,等.门冬胰岛素30联合二甲双胍及利拉鲁肽治疗肥胖2型糖尿病[J].西部医学,2020,32(10):1509-1512.
[20] 付 琳,付 强,李 冀,等.黄连化学成分及药理作用研究进展[J].中医药学报,2021,49(2):87-92.
[21] 田会东,王 静,郭丽娜,等.基于网络药理学的“苍术-玄参”药对抗2型糖尿病作用机制研究[J].中国现代应用药学,2020,37(2):165-169.
相似文献/References:
[1]罗荔.降糖饮联合西药治疗儿童1型糖尿病44例[J].陕西中医,2016,(10):1299.
[2]单亮亮,邓小敏,王振刚,等.五味消渴方治疗糖尿病机理探析[J].陕西中医,2017,(06):783.
[3]王巍,赵平.参芪麦味地黄汤联合运动疗法对妊娠期糖尿病气阴两虚型患者 糖脂代谢及妊娠结局的影响*[J].陕西中医,2018,(10):1339.
[4]王颖.益气降糖饮联合胰岛素对妊娠期糖尿病孕妇血糖、 内脂素水平及妊娠结局的影响*[J].陕西中医,2018,(10):1342.
Wang Ying..Effects of Yiqi Jiangtang decoction combined with insulin on blood glucose， visfatin level and pregnancy outcome in patients with gestational diabetes mellitus[J].,2018,(5):1342.
[5]张 新.益气养血汤联合痔炎冲洗灵治疗肛周脓肿合并糖尿病患者切开〖JZ〗对口引流挂线术后创面愈合的影响[J].陕西中医,2019,(3):368.
[6]刘 辉,王连伟,乔 飞,等.知柏地黄汤联合个体化营养支持治疗糖尿病合并肺结核疗效及对患者T淋巴细胞亚群的影响*[J].陕西中医,2019,(1):76.
[7]杨 敏,姜钧文,肖 蕾.中医体质与急性心肌梗死及其危险因素的相关性研究*[J].陕西中医,2019,(4):437.
YANG Min,JIANG Junwen,XIAO Lei..Study on the correlation between constitution of traditional Chinese medicine and acute myocardial infarction and its risk factors[J].,2019,(5):437.
[8]秦福芳,阎 磊,申凤娟,等.血必净注射液治疗老年糖尿病合并急性肾盂肾炎疗效研究[J].陕西中医,2019,(4):456.
QIN Fufang,SHEN Fengjuan,SHAO Fengmin..Effect of Xuebijing injection on acute pyelonephritis in elderly patients with diabetes[J].,2019,(5):456.
[9]刘 扬,韩家凯,王 前.麝香养心散治疗糖尿病合并冠状动脉粥样硬化性心脏病 及对患者血脂、血流变与凝血功能的影响*[J].陕西中医,2019,(5):576.
LIU Yang,HAN Jiakai,WANG Qian..Effect of Shexiang Yangxin powder on diabetic mellitus complicated with coronary atherosclerotic heart disease and its influence on blood lipid, hemorheological index and coagulation function〖WT4”BZ〗[J].,2019,(5):576.
[10]何 丽,朱亚丽,罗 方,等.盐酸帕罗西汀片联合养阴益气中药治疗糖尿病合并抑郁症 疗效研究*[J].陕西中医,2019,(5):645.
HE Li,ZHU Yali,LUO Fang,et al.Effects of paroxetine hydrochloride tablets combined with Yangyin Yiqi TCM on SDS，DQOL and TESS score in diabetic patients with depression[J].,2019,(5):645.